BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Bio NC

  Conversion Right Triggered for Laboratory Corporation of America Holdings (LabCorp)’s Zero Coupon Convertible Subordinated Notes Due 2021

  July 2, 2012

   · 

  1 min read
• BioCapital

  Cytomedix Inc. Announces Extension of Exclusivity Period to Global Pharmaceutical Company for Autologel System in Chronic Wound Market

  July 2, 2012

   · 

  6 min read
• Protalix Biotherapeutics, Inc. Announces New Clinical Data on taliglucerase alfa Presented at the 10th Annual European Working Group on Gaucher Disease Meeting

  July 2, 2012

   · 

  1 min read
• Pharm Country

  Amarin Corporation PLC Announces Notice of Allowance for Additional U.S. Patent Covering AMR101

  July 2, 2012

   · 

  1 min read
• Drug Development

  Onyx Pharmaceuticals, Inc. Initiates Phase 3 Kyprolis™ Head-to-Head Comparison Trial vs. Velcade® in Patients With Relapsed Multiple Myeloma

  July 2, 2012

   · 

  5 min read
• Biotech Bay

  Verinata Health, Inc. Expands verifi™ Prenatal Test to Include Turner Syndrome Option

  July 2, 2012

   · 

  3 min read
• Biotech Beach

  AVANIR Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application Covering NUEDEXTA

  July 2, 2012

   · 

  7 min read
• Business

  AstraZeneca PLC, Bristol-Myers Squibb Company Join Forces in $7 Billion Deal for Amylin Pharmaceuticals, Inc.

  July 2, 2012

   · 

  1 min read
• Policy

  Johnson & Johnson Seeks Approval for Resistant TB Drug

  July 2, 2012

   · 

  8 min read
• Drug Development

  GlaxoSmithKline, Theravance, Inc. Lung Drug Shows Positive Trial Results

  July 2, 2012

   · 

  10 min read